可卡因诱导的喘和"肺":一个病例报告
Victor A López-Félix1, Luis A González-Torres1, Alan Gamboa-Meza2
1Internal Medicine, Hospital José Eleuterio Gonzalez, Universidad Autónoma de Nuevo León, Monterrey, MEX.
Cureus
|March 11, 2024
概括
可卡因使用可以导致裂肺综合征 (CLS),模仿喘恶化. 早期诊断和治疗,包括支气管扩展剂和类固醇,对于管理这种情况和预防严重呼吸道困扰至关重要.
科学领域:
- 肺部病理学 肺部病理学
- 毒理学 毒理学 毒理学
- 紧急医疗 紧急医疗
背景情况:
- 可卡因是一种广泛使用的非法药物,具有显著的心血管和肺部并发症.
- 破裂肺综合征 (CLS) 是一种严重的肺部疾病,与可卡因吸入有关,可能会加剧先前存在的呼吸系统问题.
- 这个病例涉及一个患有喘的患者,在使用可卡因后出现了与喘危机一致的症状.
研究的目的:
- 报告一个裂肺综合征 (CLS) 病例与喘恶化同时发生.
- 要强调诊断挑战和管理策略,在患有喘的患者中对CLS进行治疗.
- 突出临床怀疑和支气管镜检查在诊断CLS中的重要性.
主要方法:
- 一名28岁的女性患有控制喘,在吸入可卡因后出现症状.
- 诊断包括放射学研究和支气管镜检查,证实了CLS.
- 治疗包括氧气,支气管扩展剂和类固醇,并进行持续监测.
主要成果:
- 患者最初经历了持续的喘危机,尽管标准治疗.
- 放射学研究和支气管镜检查证实了CLS.
- 在治疗后48小时内,肺部透物完全回归.
结论:
- 慢性肺炎症可以模仿或与喘恶化同时发生,需要高临床怀疑指数.
- 支气管镜是CLS的一个有价值的诊断工具,它补充了像CT扫描这样的成像研究.
- 有效的管理包括支气管扩展剂,类固醇,氧气,至关重要的是,可卡因禁欲.
相关概念视频
01:29Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
01:24Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:26Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
01:30Acute Respiratory Failure-III
184
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
184